Fact sheet: SEB Lakemedels

Fund information

Fund name
SEB Lakemedels SEK
Fund company manager
SEB Asset Management SA
Fund type
SIB
Fund manager
Ulrika Bergman
since 15/04/1988
Fund objective
The Fund is an actively managed fund that invests in equity and equity related instruments of the health care sector worldwide.
Benchmark
MSCI World Healthcare
Investment style
None
Investment method
Shares

Quick stats

1 Year return

4.01 %

1 Year rank in sector

23/29

Sector

FO Equity - Pharma Health & Biotech

Yield
-
Fund size

£ 8.9 b

FE Risk score

141

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • International
    99%
  • Money Market
    1%
  • Pharmaceuticals
    42%
  • Biotechnology/Medical
    34%
  • Healthcare & Medical Products
    23%
  • Money Market
    1%
  • International Equities
    99%
  • Money Market
    1%

Performance vs. Sector

Cumulative performance

1m6m1y3y5y
Fund4.05 %-0.85 %4.01 %26.6 %123.29 %
Sector4.51 %4.02 %9.81 %21.13 %99.13 %
Rank within sector18 / 3023 / 3023 / 298 / 276 / 23
Quartile th3 rd4 th4 th2 nd2 nd

Calendar performance

YTD-20172016201520142013
Fund4.19 %-5.18 %15.66 %45.23 %30.74 %
Sector15.98 %-9.92 %7.24 %28.08 %41.03 %
Rank within sector25 / 298 / 294 / 272 / 2419 / 23
Quartile th4 th2 nd1 st1 st4 th

Risk statistics

Alpha2.39
Beta0.87
Sharpe0.33
Volatility15.71
Tracking error8.65
Information ratio0.15
R-Squared0.72

Price movement

52 week high16.5912
52 week low13.9359
Current bid price0
Current offer price0
Current mid price15.2866

Holdings by region

  • 99% International
  • 1% Money Market

Holdings by sector

  • 42% Pharmaceuticals
  • 34% Biotechnology/Medical
  • 23% Healthcare & Medical Products
  • 1% Money Market

Holdings by asset type

  • 99% International Equities
  • 1% Money Market

Individual holdings

  • 9.13% JOHNSON & JOHNSON
  • 6.61% ROCHE HLDG AG
  • 6.35% PFIZER INC
  • 5.59% AMGEN INC
  • 5.25% BAYER AG
  • 3.73% GILEAD SCIENCES INC
  • 3.69% EXPRESS SCRIPTS HLDG CO
  • 3.53% HCA HEALTHCARE INC
  • 3.41% ABBVIE INC
  • 3.34% UNITED THERAPEUTICS CORP